(Q38198157)

30 August 2017

1 reference

title

Antimicrobial stewardship of β-lactams in intensive care units (English)

1 reference

30 August 2017

Menino Osbert Cotta

1

0 references

Alexis Tabah

Alexis Tabah

3

0 references

Jason A. Roberts

Jason A Roberts

2

0 references

Jeffrey Lipman

Jeffrey Lipman

4

0 references

Stijn Blot

6

Stijn Blot

1 reference

30 August 2017

Dirk Vogelaers

5

1 reference

30 August 2017

publication date

22 March 2014

1 reference

Expert Review of Anti-infective Therapy

30 August 2017

published in

1 reference

30 August 2017

volume

12

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

581-595

1 reference

Industrial production of beta-lactam antibiotics

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

The use and resistance to antibiotics in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A European study on the relationship between antimicrobial use and antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Gram-negative resistance: can we combat the coming of a new "Red Plague"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Evaluation of new antimicrobials for the hospital formulary. Policies restricting antibiotic use in hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Antimicrobial stewardship: concepts and strategies in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Impact of antimicrobial stewardship in critical care: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Antibiotic resistance--squeezing the balloon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Antibiotic resistance: the perfect storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an Intensive Care Unit in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A cluster of fulminant, fatal necrotizing community-associated methicillin-resistant Staphylococcus aureus pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Breakpoints: current practice and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Effect of fluconazole consumption on long-term trends in candidal ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Screening for resistant gram-negative microorganisms to guide empiric therapy of subsequent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Maximizing rates of empiric appropriate antibiotic therapy with minimized use of broad-spectrum agents: are surveillance cultures the key?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Antibiotic dosing in multiple organ dysfunction syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Continuous beta-lactam infusion in critically ill patients: the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Therapeutic drug monitoring of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Using PK/PD to optimize antibiotic dosing for critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Essentials for selecting antimicrobial therapy for intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

The new treatment paradigm and the role of carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Results of a local antibiotic management program on antibiotic use in a tertiary intensive care unit in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Use of computerized decision support systems to improve antibiotic prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Computerized prescribing: building the electronic infrastructure for better medication usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Expert clinical decision support systems to enhance antimicrobial stewardship programs: insights from the society of infectious diseases pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Why don't physicians follow clinical practice guidelines? A framework for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Evidence-based guidelines for the prevention of ventilator-associated pneumonia: results of a knowledge test among European intensive care nurses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Restriction of third-generation cephalosporin use decreases infection-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Pilot study of a web-based antibiotic decision management guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Handheld computer-based decision support reduces patient length of stay and antibiotic prescribing in critical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Development and impact of a computerized pediatric antiinfective decision support program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Empiric, Broad-Spectrum Antibiotic Therapy with an Aggressive De-Escalation Strategy Does Not Induce Gram-Negative Pathogen Resistance in Ventilator-Associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

Does Antibiotic De-escalation for Nosocomial Pneumonia Impact Intensive Care Unit Length of Stay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

De-escalation therapy in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2014.902308

10.1586/14787210.2014.902308

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference